Are you Dr. Carter?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
You already have 54 invites waiting! - Read the latest clinical news, personalized to your specialty.
Office
10 Center Dr Msc 1881
Bldg 10 Rm 213
Bethesda, MD 20892Phone+1 301-496-8772Fax+1 301-480-8384
Summary
- Dr. Melody Carter, MD is an allergist/immunologist in Bethesda, Maryland. She is currently licensed to practice medicine in Georgia and Louisiana.
Education & Training
- National Institutes of Health Clinical CenterFellowship, Allergy and Immunology, 1999 - 2001
- Emory University School of MedicineResidency, Pediatrics, 1981 - 1984
- Tulane University School of MedicineClass of 1981
Certifications & Licensure
- GA State Medical License 1984 - 2025
- LA State Medical License 1981 - 1994
- American Board of Pediatrics Pediatrics
Clinical Trials
- Cause of Unexplained Anaphylaxis Start of enrollment: 2008 Nov 05
Publications & Presentations
PubMed
- 122 citationsOmalizumab for the treatment of unprovoked anaphylaxis in patients with systemic mastocytosisMelody C. Carter, Jamie Robyn, Peter B. Bressler, John C. Walker, Gail G. Shapiro
The Journal of Allergy and Clinical Immunology. 2007-06-01 - 401 citationsExpansion of the Human Phenotype Ontology (HPO) knowledge base and resourcesSebastian Köhler, Leigh C. Carmody, Nicole Vasilevsky, Julius O.B. Jacobsen, Daniel Danis
Nucleic Acids Research. 2019-01-08 - 133 citationsHome intervention in the treatment of asthma among inner-city childrenMelody C. Carter, A. Matthew S. Perzanowski, Amos Raymond, Thomas A.E. Platts-Mills
The Journal of Allergy and Clinical Immunology. 2001-11-01
Press Mentions
- New Yardstick Offers Guidance for the Management and Diagnosis of Idiopathic AnaphylaxisSeptember 20th, 2019
- New Yardstick Offers Diagnostic and Treatment Guidance for Idiopathic AnaphylaxisSeptember 18th, 2019